Relationships between Brain Structure and Metabolic Changes in Schizophrenia Patients Treated with Olanzapine: A Voxel-Based Morphometric Study
- PMID: 22937275
- PMCID: PMC3420802
- DOI: 10.1155/2011/862350
Relationships between Brain Structure and Metabolic Changes in Schizophrenia Patients Treated with Olanzapine: A Voxel-Based Morphometric Study
Abstract
Introduction. Second-generation antipsychotics treatment is associated with weight gain and metabolic disturbances. Although much research has been done on the topic, the precise mechanisms underlying such side effects are still not well understood. Method. We followed over 16 weeks a group of 17 schizophrenia patients who were treated with olanzapine and monitored biometric, clinical, and metabolic data, including ghrelin and leptin levels. All patients had a structural cerebral magnetic resonance imaging examination during the first week of their followup and at the end of the study. Results. We found positive and negative significant correlations between grey matter volumes of several brain regions and variations of body weight as well as of ghrelin and leptin levels. The right frontal operculum, bilateral precuneus, and bilateral hippocampal regions were found to be significantly associated with those changes. Conclusion. Our results suggest associations between brain structure and metabolic variations in schizophrenia patients taking olanzapine.
Similar articles
-
Body weight and plasma levels of ghrelin and leptin during treatment with olanzapine.J Korean Med Sci. 2008 Aug;23(4):685-90. doi: 10.3346/jkms.2008.23.4.685. J Korean Med Sci. 2008. PMID: 18756058 Free PMC article.
-
Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin.Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr 3;58:47-50. doi: 10.1016/j.pnpbp.2014.12.001. Epub 2014 Dec 9. Prog Neuropsychopharmacol Biol Psychiatry. 2015. PMID: 25496829
-
Early effects of olanzapine on serum levels of ghrelin, adiponectin and leptin in patients with schizophrenia.J Psychopharmacol. 2006 Jan;20(1):75-9. doi: 10.1177/0269881105056647. Epub 2005 Oct 4. J Psychopharmacol. 2006. PMID: 16204328 Clinical Trial.
-
Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.Clin Drug Investig. 2011;31(7):455-82. doi: 10.2165/11589060-000000000-00000. Clin Drug Investig. 2011. PMID: 21495734 Review.
-
Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review.Schizophr Bull. 2008 Nov;34(6):1189-99. doi: 10.1093/schbul/sbm141. Epub 2007 Dec 28. Schizophr Bull. 2008. PMID: 18165262 Free PMC article. Review.
References
-
- De Hert M, Schreurs V, Sweers K, et al. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review. Schizophrenia Research. 2008;101(1–3):295–303. - PubMed
-
- Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry. 2002;159(4):561–566. - PubMed
-
- Casey DE, Haupt DW, Newcomer JW, et al. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. Journal of Clinical Psychiatry. 2004;65(supplement 7):4–18. - PubMed
-
- Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. Journal of Clinical Psychiatry. 2001;62(4):231–238. - PubMed
-
- Bai YM, Lin CC, Chen JY, Lin CY, Su TP, Chou P. Association of initial antipsychotic response to clozapine and long-term weight gain. American Journal of Psychiatry. 2006;163(7):1276–1279. - PubMed
LinkOut - more resources
Full Text Sources
Medical